Hearing Aids Reduce Dementia Risk in Epilepsy
Analysis based on 17 articles · First reported Jun 26, 2026 · Last updated Jun 26, 2026
The research suggests a potential new market for hearing aid manufacturers, particularly those targeting patients with epilepsy, as it highlights a specific benefit beyond just hearing improvement. This could lead to increased demand and investment in hearing aid technology and related healthcare services. Pharmaceutical companies might also see implications for anti-seizure medications if hearing loss is exacerbated by them.
New research presented at the American Academy of Neurology Congress 2026 indicates that adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia. This finding, led by Dr. Carolina Ferreira-Atuesta from University Hospital of Zurich and the University of Liverpool, was derived from analyzing electronic health records of over 250 million patients in the TriNetX network. While no significant association was found in the general hearing-loss population or other high-risk groups, the specific link in epilepsy patients is attributed to differences in cognitive reserve. The study suggests important implications for clinical practice, advocating for routine hearing assessments for people with epilepsy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard